Essex Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
Other funds holding CDMO
AC
RIM
GCM
SCM
Essex Investment Management's CDMO Position: Q2 2023 in Review
Essex Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2023, closing a stake of 119,112 shares — an estimated $2.23M sold.
Essex Investment Management first reported a position in CDMO in Q1 2019 and held it in 17 quarters. The position peaked at $6.11M in Q2 2021. 169 funds tracked by Wall St. Rank hold CDMO as of Q2 2023.
- Essex Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Essex Investment Management sold 119,112 Avid Bioservices, Inc. Common Stock shares in Q2 2023, an estimated $2.23M.
- Essex Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2019 and held it in 17 quarters.
- Essex Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $6.11M in Q2 2021.
- 169 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2023.
Based on Essex Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.